BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26139072)

  • 61. Sensitive LC-MS/MS-ESI method for simultaneous determination of nifedipine and atenolol in human plasma and its application to a human pharmacokinetic study.
    Kallem RR; Inamadugu JK; Ramesh M; Seshagirirao JV
    Biomed Chromatogr; 2013 Mar; 27(3):349-55. PubMed ID: 22886904
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
    Honeywell R; Yarzadah K; Giovannetti E; Losekoot N; Smit EF; Walraven M; Lind JS; Tibaldi C; Verheul HM; Peters GJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1059-68. PubMed ID: 20382575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and validation of a sensitive LC-MS/MS-ESI method for the determination of ivabradine in human plasma: application to a pharmacokinetic study.
    Jiang J; Tian L; Huang Y; Li Y
    Biomed Chromatogr; 2013 Dec; 27(12):1603-8. PubMed ID: 23798342
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liquid chromatography tandem mass spectrometry method for the quantitative analysis of ceritinib in human plasma and its application to pharmacokinetic studies.
    Heudi O; Vogel D; Lau YY; Picard F; Kretz O
    Anal Bioanal Chem; 2014 Nov; 406(28):7389-96. PubMed ID: 25258279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.
    Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():174-7. PubMed ID: 22476054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An LC-MS/MS method for the quantitation of cabozantinib in rat plasma: application to a pharmacokinetic study.
    Su Q; Li J; Ji X; Li J; Zhou T; Lu W; Li L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():119-23. PubMed ID: 25678398
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.
    Trivedi RK; Kallem RR; Mullangi R; Srinivas NR
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):661-9. PubMed ID: 15970417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; He B; Mylott W; Zhao S; Mariannino T; Shen J; Stouffer B
    J Pharm Biomed Anal; 2012 Nov; 70():574-9. PubMed ID: 22709607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of norelgestromin in rabbit plasma by LC-MS/MS and its application to the pharmacokinetic study of ORTHO EVRA.
    Liu X; Ding C; Ge Q; Zhi X; Zhou Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):311-5. PubMed ID: 19097950
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans.
    Li P; Chen X; Dai X; Wen A; Zhang Y; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):479-84. PubMed ID: 17329173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Simultaneous determination of sitagliptin and simvastatin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
    Burugula L; Mullangi R; Pilli NR; Makula A; Lodagala DS; Kandhagatla R
    Biomed Chromatogr; 2013 Jan; 27(1):80-7. PubMed ID: 22544712
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of a sensitive LC/MS/MS method for simultaneous quantitation of flupentixol and melitracene in human plasma.
    Che J; Meng Q; Chen Z; San C; Hou Y; Cheng Y
    J Pharm Biomed Anal; 2007 Dec; 45(5):785-92. PubMed ID: 17881181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of pseudo-ginsenoside GQ in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Huo J; Wang H; Hu P; Li P; Liu J; Jiang J
    Biomed Chromatogr; 2013 Dec; 27(12):1701-7. PubMed ID: 23852954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. On-cartridge derivatization coupled with solid-phase extraction for the ultra-sensitive determination of minodronic acid in human plasma by LC-MS/MS method.
    Yang Y; Liu C; Zhang Y; Zhou L; Zhong D; Chen X
    J Pharm Biomed Anal; 2015 Oct; 114():408-15. PubMed ID: 26117452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Determination of metformin in rat plasma by HILIC-MS/MS combined with Tecan automation and direct injection.
    Zhang W; Han F; Zhao H; Lin ZJ; Huang QM; Weng N
    Biomed Chromatogr; 2012 Oct; 26(10):1163-9. PubMed ID: 22213213
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A rapid and sensitive liquid chromatography/negative ion tandem mass spectrometry method for the determination of an indolocarbazole in human plasma using 96-well diatomaceous earth plates for solid-liquid extraction [correction of using internal standard (IS) 96-well diatomaceous earth plates for solid-liquid extraction].
    Wang AQ; Zeng W; Musson DG; Rogers JD; Fisher AL
    Rapid Commun Mass Spectrom; 2002; 16(10):975-81. PubMed ID: 11968130
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of tamsulosin in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
    Choi CI; Lee HI; Bae JW; Lee YJ; Byeon JY; Jang CG; Lee SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():65-9. PubMed ID: 23153646
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
    J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study.
    Nag S; Qin JJ; Patil S; Deokar H; Buolamwini JK; Wang W; Zhang R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():235-240. PubMed ID: 25195025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.